-
1
-
-
64749100501
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
American Diabetes Association; European Association for Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
2
-
-
34247131681
-
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys
-
DOI 10.1111/j.1742-1241.2007.01336.x
-
Bays HE, Chapman RH, Grandy S; SHIELD Investigators' Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007;61:737-747 (Pubitemid 46587875)
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.5
, pp. 737-747
-
-
Bays, H.E.1
Chapman, R.H.2
Grandy, S.3
-
3
-
-
0030778116
-
The prevention and treatment of obesity. Application to type 2 diabetes
-
Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997;20: 1744-1766
-
(1997)
Diabetes Care
, vol.20
, pp. 1744-1766
-
-
Maggio, C.A.1
Pi-Sunyer, F.X.2
-
4
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
5
-
-
17744395778
-
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance
-
Charpentier G, Fleury F, Dubroca I, Vaur L, Clerson P. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab 2005;31: 189-195 (Pubitemid 40577203)
-
(2005)
Diabetes and Metabolism
, vol.31
, Issue.2
, pp. 189-195
-
-
Charpentier, G.1
Fleury, F.2
Dubroca, I.3
Vaur, L.4
Clerson, P.5
-
6
-
-
0000078123
-
Recommendations for evaluating the validity of quality of life claims for labeling and promotion
-
Leidy NK, Revicki DA, Genesté B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113-127
-
(1999)
Value Health
, vol.2
, pp. 113-127
-
-
Leidy, N.K.1
Revicki, D.A.2
Genesté, B.3
-
8
-
-
14244255984
-
The DIAB.&TE.S Project: How patients perceive diabetes and diabetes therapy
-
DIAB. & TE.S Project Study Group
-
Marra G; DIAB. & TE.S Project Study Group. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy. Acta Biomed 2004;75:164-170
-
(2004)
Acta Biomed
, vol.75
, pp. 164-170
-
-
Marra, G.1
-
9
-
-
67649774247
-
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily
-
Best JH, Boye KS, Rubin RR, Cao D, Kim TH, Peyrot M. Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. Diabet Med 2009;26:722-728
-
(2009)
Diabet Med
, vol.26
, pp. 722-728
-
-
Best, J.H.1
Boye, K.S.2
Rubin, R.R.3
Cao, D.4
Kim, T.H.5
Peyrot, M.6
-
10
-
-
70349675747
-
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: Which is better?
-
Lingvay I, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P. Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better? Diabetes Care 2009;32:1789-1795
-
(2009)
Diabetes Care
, vol.32
, pp. 1789-1795
-
-
Lingvay, I.1
Legendre, J.L.2
Kaloyanova, P.F.3
Zhang, S.4
Adams-Huet, B.5
Raskin, P.6
-
11
-
-
1242283924
-
Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: A prospective, randomized trial
-
DOI 10.1016/j.amjmed.2003.07.023
-
Aljabri K, Kozak SE, Thompson DM. Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial. Am J Med 2004;116: 230-235 (Pubitemid 38224230)
-
(2004)
American Journal of Medicine
, vol.116
, Issue.4
, pp. 230-235
-
-
Aljabri, K.1
Kozak, S.E.2
Thompson, D.M.3
-
12
-
-
33645988220
-
Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): The Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study
-
RESULT Study Group
-
Rosenstock J, Goldstein BJ, Vinik AI, et al.; RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. Diabetes Obes Metab 2006;8:49-57
-
(2006)
Diabetes Obes Metab
, vol.8
, pp. 49-57
-
-
Rosenstock, J.1
Goldstein, B.J.2
Vinik, A.I.3
-
13
-
-
28444440888
-
Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week,multicenter, randomized, double-blind, parallel-group study
-
Bailey CJ, Bagdonas A, Rubes J, et al. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week,multicenter, randomized, double-blind, parallel-group study.Clin Ther 2005; 27:1548-1561
-
(2005)
Clin Ther
, vol.27
, pp. 1548-1561
-
-
Bailey, C.J.1
Bagdonas, A.2
Rubes, J.3
-
14
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
Action to Control Cardiovascular Risk in Diabetes Study Group
-
Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
Gerstein, H.C.1
Miller, M.E.2
Byington, R.P.3
-
15
-
-
0031578033
-
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects
-
World Medical Association Declaration of Helsinki
-
World Medical Association Declaration of Helsinki. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277:925-926
-
(1997)
JAMA
, vol.277
, pp. 925-926
-
-
-
16
-
-
77955573674
-
A comparison of the efficacy and safety of exenatide once weekly, sitagliptin, and pioglitazone when added to metformin in the treatment of type 2 diabetes. DURATION-2: A randomized trial
-
for the DURATION-2 Study Group
-
Bergenstal RM. Wysham, MacConell L, Malloy J, Yan P, Wilhelm K, Malone J, Porter LE, for the DURATION-2 Study Group: A comparison of the efficacy and safety of exenatide once weekly, sitagliptin, and pioglitazone when added to metformin in the treatment of type 2 diabetes. DURATION-2: a randomized trial. Lancet 2010;376:431-439
-
(2010)
Lancet
, vol.376
, pp. 431-439
-
-
Bergenstal, R.M.1
Wysham MacConell, L.2
Malloy, J.3
Yan, P.4
Wilhelm, K.5
Malone, J.6
Porter, L.E.7
-
17
-
-
0042388520
-
Assessing weight-related quality of life in obese persons with type 2 diabetes
-
DOI 10.1016/S0168-8227(03)00113-X
-
Kolotkin RL, Crosby RD, Williams GR. Assessing weight-related quality of life in obese persons with type 2 diabetes. Diabetes Res Clin Pract 2003;61:125-132 (Pubitemid 37013657)
-
(2003)
Diabetes Research and Clinical Practice
, vol.61
, Issue.2
, pp. 125-132
-
-
Kolotkin, R.L.1
Crosby, R.D.2
Williams, G.R.3
-
18
-
-
0036071652
-
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
-
DOI 10.1177/027298902400448902
-
Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22:340-349 (Pubitemid 34791321)
-
(2002)
Medical Decision Making
, vol.22
, Issue.4
, pp. 340-349
-
-
Clarke, P.1
Gray, A.2
Holman, R.3
-
19
-
-
35649023181
-
Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
-
Matza LS, Boye KS, Yurgin N. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Health Qual Life Outcomes 2007;5:47
-
(2007)
Health Qual Life Outcomes
, vol.5
, pp. 47
-
-
Matza, L.S.1
Boye, K.S.2
Yurgin, N.3
-
22
-
-
68149116304
-
How does treatment satisfaction work? Modeling determinants of treatment satisfaction and preference
-
Peyrot M, Rubin RR. How does treatment satisfaction work? Modeling determinants of treatment satisfaction and preference. Diabetes Care 2009;32:1411-1417
-
(2009)
Diabetes Care
, vol.32
, pp. 1411-1417
-
-
Peyrot, M.1
Rubin, R.R.2
-
23
-
-
77956707365
-
Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin
-
Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Prim Care Diabetes 2010;4:113-117
-
(2010)
Prim Care Diabetes
, vol.4
, pp. 113-117
-
-
Hermansen, K.1
Kolotkin, R.L.2
Hammer, M.3
Zdravkovic, M.4
Matthews, D.5
-
24
-
-
74849099588
-
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
-
Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010;87: 204-210
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 204-210
-
-
Pollack, M.F.1
Purayidathil, F.W.2
Bolge, S.C.3
Williams, S.A.4
-
25
-
-
65649111800
-
Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications
-
Bharmal M, Payne K, Atkinson MJ, Desrosiers M-P, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009;7:36
-
(2009)
Health Qual Life Outcomes
, vol.7
, pp. 36
-
-
Bharmal, M.1
Payne, K.2
Atkinson, M.J.3
Desrosiers, M.-P.4
Morisky, D.E.5
Gemmen, E.6
|